Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-006990

Chief Scientific Officer acquired 81,006 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Leen Ann M. · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Owned after D/I
2022-01-18 Grant or award : show line 1 in the form +23,256 51,256 D
2022-07-01 Grant or award : show line 2 in the form +14,000 65,256 D
2023-02-02 Grant or award : show line 3 in the form +43,750 124,006 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-01-18 Grant or award : show line 4 in the form Stock Option (Right to Buy) +56,744 366,344 D
2022-07-01 Grant or award : show line 5 in the form Stock Option (Right to Buy) +26,000 392,344 D
2023-02-02 Grant or award : show line 6 in the form Stock Option (Right to Buy) +81,250 473,594 D
Loading xslF345X03/doc4.xml…